 | • レポートコード：MRC2-11QY04681 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は軟部肉腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、抗血管新生薬、放射線療法）市場規模、用途別（病院、腫瘍学センター、介護センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別軟部肉腫治療の競争状況、市場シェア ・世界の軟部肉腫治療市場：種類別市場規模 2015年-2020年（化学療法、標的療法、抗血管新生薬、放射線療法） ・世界の軟部肉腫治療市場：種類別市場規模予測 2021年-2026年（化学療法、標的療法、抗血管新生薬、放射線療法） ・世界の軟部肉腫治療市場：用途別市場規模 2015年-2020年（病院、腫瘍学センター、介護センター） ・世界の軟部肉腫治療市場：用途別市場規模予測 2021年-2026年（病院、腫瘍学センター、介護センター） ・北米の軟部肉腫治療市場分析：米国、カナダ ・ヨーロッパの軟部肉腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの軟部肉腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の軟部肉腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの軟部肉腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BioHorizons、Biomet、Geistlich、Smith & Nephew、RTI Biologics、MiMedx、LifeCell、Atrium Medical、Zimmer Holdings、Cook Medical、Dentsply、Medtronic、Stryker、Ethicon、Boston Scientific、American Medical Systems、Integra LifeSciences and Citagenix ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues.
Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market.
Market Analysis and Insights: Global Soft Tissue Sarcoma Treatment Market
The global Soft Tissue Sarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Soft Tissue Sarcoma Treatment Scope and Market Size
Soft Tissue Sarcoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Soft Tissue Sarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
BioHorizons
Biomet
Geistlich
Smith & Nephew
RTI Biologics
MiMedx
LifeCell
Atrium Medical
Zimmer Holdings
Cook Medical
Dentsply
Medtronic
Stryker
Ethicon
Boston Scientific
American Medical Systems
Integra LifeSciences and Citagenix
Market segment by Type, the product can be split into
Chemotherapy
Targeted Therapy
Anti-angiogenesis drugs
Radiation Therapy
Market segment by Application, split into
Hospitals
Oncology Centers
Long Term Care Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Soft Tissue Sarcoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Soft Tissue Sarcoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Targeted Therapy
1.4.4 Anti-angiogenesis drugs
1.4.5 Radiation Therapy
1.5 Market by Application
1.5.1 Global Soft Tissue Sarcoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology Centers
1.5.4 Long Term Care Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Soft Tissue Sarcoma Treatment Market Perspective (2015-2026)
2.2 Global Soft Tissue Sarcoma Treatment Growth Trends by Regions
2.2.1 Soft Tissue Sarcoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Soft Tissue Sarcoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Soft Tissue Sarcoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Soft Tissue Sarcoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Soft Tissue Sarcoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Soft Tissue Sarcoma Treatment Players by Market Size
3.1.1 Global Top Soft Tissue Sarcoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Soft Tissue Sarcoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Soft Tissue Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Soft Tissue Sarcoma Treatment Market Concentration Ratio
3.2.1 Global Soft Tissue Sarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Soft Tissue Sarcoma Treatment Revenue in 2019
3.3 Soft Tissue Sarcoma Treatment Key Players Head office and Area Served
3.4 Key Players Soft Tissue Sarcoma Treatment Product Solution and Service
3.5 Date of Enter into Soft Tissue Sarcoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Soft Tissue Sarcoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Soft Tissue Sarcoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
5.2 Global Soft Tissue Sarcoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Soft Tissue Sarcoma Treatment Market Size (2015-2020)
6.2 Soft Tissue Sarcoma Treatment Key Players in North America (2019-2020)
6.3 North America Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
6.4 North America Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Soft Tissue Sarcoma Treatment Market Size (2015-2020)
7.2 Soft Tissue Sarcoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
7.4 Europe Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Soft Tissue Sarcoma Treatment Market Size (2015-2020)
8.2 Soft Tissue Sarcoma Treatment Key Players in China (2019-2020)
8.3 China Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
8.4 China Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Soft Tissue Sarcoma Treatment Market Size (2015-2020)
9.2 Soft Tissue Sarcoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
9.4 Japan Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Soft Tissue Sarcoma Treatment Market Size (2015-2020)
10.2 Soft Tissue Sarcoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Soft Tissue Sarcoma Treatment Market Size (2015-2020)
11.2 Soft Tissue Sarcoma Treatment Key Players in India (2019-2020)
11.3 India Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
11.4 India Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Soft Tissue Sarcoma Treatment Market Size (2015-2020)
12.2 Soft Tissue Sarcoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 BioHorizons
13.1.1 BioHorizons Company Details
13.1.2 BioHorizons Business Overview
13.1.3 BioHorizons Soft Tissue Sarcoma Treatment Introduction
13.1.4 BioHorizons Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020))
13.1.5 BioHorizons Recent Development
13.2 Biomet
13.2.1 Biomet Company Details
13.2.2 Biomet Business Overview
13.2.3 Biomet Soft Tissue Sarcoma Treatment Introduction
13.2.4 Biomet Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.2.5 Biomet Recent Development
13.3 Geistlich
13.3.1 Geistlich Company Details
13.3.2 Geistlich Business Overview
13.3.3 Geistlich Soft Tissue Sarcoma Treatment Introduction
13.3.4 Geistlich Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.3.5 Geistlich Recent Development
13.4 Smith & Nephew
13.4.1 Smith & Nephew Company Details
13.4.2 Smith & Nephew Business Overview
13.4.3 Smith & Nephew Soft Tissue Sarcoma Treatment Introduction
13.4.4 Smith & Nephew Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.4.5 Smith & Nephew Recent Development
13.5 RTI Biologics
13.5.1 RTI Biologics Company Details
13.5.2 RTI Biologics Business Overview
13.5.3 RTI Biologics Soft Tissue Sarcoma Treatment Introduction
13.5.4 RTI Biologics Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.5.5 RTI Biologics Recent Development
13.6 MiMedx
13.6.1 MiMedx Company Details
13.6.2 MiMedx Business Overview
13.6.3 MiMedx Soft Tissue Sarcoma Treatment Introduction
13.6.4 MiMedx Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.6.5 MiMedx Recent Development
13.7 LifeCell
13.7.1 LifeCell Company Details
13.7.2 LifeCell Business Overview
13.7.3 LifeCell Soft Tissue Sarcoma Treatment Introduction
13.7.4 LifeCell Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.7.5 LifeCell Recent Development
13.8 Atrium Medical
13.8.1 Atrium Medical Company Details
13.8.2 Atrium Medical Business Overview
13.8.3 Atrium Medical Soft Tissue Sarcoma Treatment Introduction
13.8.4 Atrium Medical Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.8.5 Atrium Medical Recent Development
13.9 Zimmer Holdings
13.9.1 Zimmer Holdings Company Details
13.9.2 Zimmer Holdings Business Overview
13.9.3 Zimmer Holdings Soft Tissue Sarcoma Treatment Introduction
13.9.4 Zimmer Holdings Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.9.5 Zimmer Holdings Recent Development
13.10 Cook Medical
13.10.1 Cook Medical Company Details
13.10.2 Cook Medical Business Overview
13.10.3 Cook Medical Soft Tissue Sarcoma Treatment Introduction
13.10.4 Cook Medical Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
13.10.5 Cook Medical Recent Development
13.11 Dentsply
10.11.1 Dentsply Company Details
10.11.2 Dentsply Business Overview
10.11.3 Dentsply Soft Tissue Sarcoma Treatment Introduction
10.11.4 Dentsply Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.11.5 Dentsply Recent Development
13.12 Medtronic
10.12.1 Medtronic Company Details
10.12.2 Medtronic Business Overview
10.12.3 Medtronic Soft Tissue Sarcoma Treatment Introduction
10.12.4 Medtronic Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.12.5 Medtronic Recent Development
13.13 Stryker
10.13.1 Stryker Company Details
10.13.2 Stryker Business Overview
10.13.3 Stryker Soft Tissue Sarcoma Treatment Introduction
10.13.4 Stryker Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.13.5 Stryker Recent Development
13.14 Ethicon
10.14.1 Ethicon Company Details
10.14.2 Ethicon Business Overview
10.14.3 Ethicon Soft Tissue Sarcoma Treatment Introduction
10.14.4 Ethicon Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.14.5 Ethicon Recent Development
13.15 Boston Scientific
10.15.1 Boston Scientific Company Details
10.15.2 Boston Scientific Business Overview
10.15.3 Boston Scientific Soft Tissue Sarcoma Treatment Introduction
10.15.4 Boston Scientific Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.15.5 Boston Scientific Recent Development
13.16 American Medical Systems
10.16.1 American Medical Systems Company Details
10.16.2 American Medical Systems Business Overview
10.16.3 American Medical Systems Soft Tissue Sarcoma Treatment Introduction
10.16.4 American Medical Systems Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.16.5 American Medical Systems Recent Development
13.17 Integra LifeSciences and Citagenix
10.17.1 Integra LifeSciences and Citagenix Company Details
10.17.2 Integra LifeSciences and Citagenix Business Overview
10.17.3 Integra LifeSciences and Citagenix Soft Tissue Sarcoma Treatment Introduction
10.17.4 Integra LifeSciences and Citagenix Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020)
10.17.5 Integra LifeSciences and Citagenix Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Soft Tissue Sarcoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Soft Tissue Sarcoma Treatment Revenue
Table 3. Ranking of Global Top Soft Tissue Sarcoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Soft Tissue Sarcoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted Therapy
Table 7. Key Players of Anti-angiogenesis drugs
Table 8. Key Players of Radiation Therapy
Table 9. Global Soft Tissue Sarcoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Soft Tissue Sarcoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Soft Tissue Sarcoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Soft Tissue Sarcoma Treatment Market Share by Regions (2015-2020)
Table 13. Global Soft Tissue Sarcoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Soft Tissue Sarcoma Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Soft Tissue Sarcoma Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Soft Tissue Sarcoma Treatment Players
Table 20. Global Soft Tissue Sarcoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Soft Tissue Sarcoma Treatment Market Share by Players (2015-2020)
Table 22. Global Top Soft Tissue Sarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Sarcoma Treatment as of 2019)
Table 23. Global Soft Tissue Sarcoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Soft Tissue Sarcoma Treatment Product Solution and Service
Table 26. Date of Enter into Soft Tissue Sarcoma Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Soft Tissue Sarcoma Treatment Market Size Share by Type (2015-2020)
Table 30. Global Soft Tissue Sarcoma Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Soft Tissue Sarcoma Treatment Market Size Share by Application (2015-2020)
Table 32. Global Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Soft Tissue Sarcoma Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 36. North America Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 38. North America Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 42. Europe Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 44. Europe Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 48. China Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 50. China Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 54. Japan Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 56. Japan Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 60. Southeast Asia Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 66. India Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 68. India Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Soft Tissue Sarcoma Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Soft Tissue Sarcoma Treatment Market Share (2019-2020)
Table 72. Central & South America Soft Tissue Sarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Soft Tissue Sarcoma Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Soft Tissue Sarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Soft Tissue Sarcoma Treatment Market Share by Application (2015-2020)
Table 76. BioHorizons Company Details
Table 77. BioHorizons Business Overview
Table 78. BioHorizons Product
Table 79. BioHorizons Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 80. BioHorizons Recent Development
Table 81. Biomet Company Details
Table 82. Biomet Business Overview
Table 83. Biomet Product
Table 84. Biomet Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 85. Biomet Recent Development
Table 86. Geistlich Company Details
Table 87. Geistlich Business Overview
Table 88. Geistlich Product
Table 89. Geistlich Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 90. Geistlich Recent Development
Table 91. Smith & Nephew Company Details
Table 92. Smith & Nephew Business Overview
Table 93. Smith & Nephew Product
Table 94. Smith & Nephew Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 95. Smith & Nephew Recent Development
Table 96. RTI Biologics Company Details
Table 97. RTI Biologics Business Overview
Table 98. RTI Biologics Product
Table 99. RTI Biologics Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 100. RTI Biologics Recent Development
Table 101. MiMedx Company Details
Table 102. MiMedx Business Overview
Table 103. MiMedx Product
Table 104. MiMedx Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 105. MiMedx Recent Development
Table 106. LifeCell Company Details
Table 107. LifeCell Business Overview
Table 108. LifeCell Product
Table 109. LifeCell Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 110. LifeCell Recent Development
Table 111. Atrium Medical Business Overview
Table 112. Atrium Medical Product
Table 113. Atrium Medical Company Details
Table 114. Atrium Medical Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 115. Atrium Medical Recent Development
Table 116. Zimmer Holdings Company Details
Table 117. Zimmer Holdings Business Overview
Table 118. Zimmer Holdings Product
Table 119. Zimmer Holdings Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 120. Zimmer Holdings Recent Development
Table 121. Cook Medical Company Details
Table 122. Cook Medical Business Overview
Table 123. Cook Medical Product
Table 124. Cook Medical Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 125. Cook Medical Recent Development
Table 126. Dentsply Company Details
Table 127. Dentsply Business Overview
Table 128. Dentsply Product
Table 129. Dentsply Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 130. Dentsply Recent Development
Table 131. Medtronic Company Details
Table 132. Medtronic Business Overview
Table 133. Medtronic Product
Table 134. Medtronic Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 135. Medtronic Recent Development
Table 136. Stryker Company Details
Table 137. Stryker Business Overview
Table 138. Stryker Product
Table 139. Stryker Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 140. Stryker Recent Development
Table 141. Ethicon Company Details
Table 142. Ethicon Business Overview
Table 143. Ethicon Product
Table 144. Ethicon Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 145. Ethicon Recent Development
Table 146. Boston Scientific Company Details
Table 147. Boston Scientific Business Overview
Table 148. Boston Scientific Product
Table 149. Boston Scientific Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 150. Boston Scientific Recent Development
Table 151. American Medical Systems Company Details
Table 152. American Medical Systems Business Overview
Table 153. American Medical Systems Product
Table 154. American Medical Systems Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 155. American Medical Systems Recent Development
Table 156. Integra LifeSciences and Citagenix Company Details
Table 157. Integra LifeSciences and Citagenix Business Overview
Table 158. Integra LifeSciences and Citagenix Product
Table 159. Integra LifeSciences and Citagenix Revenue in Soft Tissue Sarcoma Treatment Business (2015-2020) (Million US$)
Table 160. Integra LifeSciences and Citagenix Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Tissue Sarcoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Anti-angiogenesis drugs Features
Figure 5. Radiation Therapy Features
Figure 6. Global Soft Tissue Sarcoma Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Oncology Centers Case Studies
Figure 9. Long Term Care Centers Case Studies
Figure 10. Soft Tissue Sarcoma Treatment Report Years Considered
Figure 11. Global Soft Tissue Sarcoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Soft Tissue Sarcoma Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Soft Tissue Sarcoma Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Soft Tissue Sarcoma Treatment Market Share by Players in 2019
Figure 16. Global Top Soft Tissue Sarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Sarcoma Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Soft Tissue Sarcoma Treatment Revenue in 2019
Figure 18. North America Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Soft Tissue Sarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
心血管・軟部組織修復パッチの世界市場（～2026年） Cardiovascular and soft tissue are manufactured by ePTFE and biomaterial. Owing to the increasing prevalence of congenital heart diseases such as ventricular septal defect, atrial septal defect and common atrium, the cardiovascular and soft tissue repair patches market is expected to grow rapidly ov…- 整形外科用軟組織修復の世界市場（～2026年） Soft tissue includes tendons, ligaments, fascia, skin, fibrous tissues, fat, and synovial membranes (which are connective tissue), and muscles, nerves and blood vessels (which are not connective tissue). The primary growth factor is sport injuries, which is estimated to contribute to a great extent …
- 滑膜肉腫治療の世界市場（～2026年） Market Analysis and Insights: Global Synovial Sarcoma Treatment Market The global Synovial Sarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Synovial Sarcoma Treatment Scope and Market Size Synovial Sar…
- 軟組織同種移植の世界市場（～2026年） Soft tissue refers to human skin, subcutaneous tissue, muscle, tendon, ligament, joint capsule, synovial capsule, nerve, blood vessel, etc. Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market. …
- 軟組織強化・再生の世界市場（～2026年） Soft tissue reinforcement treatment involves harvesting a small piece of soft tissue from other part of the body and placing it in the place of damaged soft tissue in order to support it. Rising disposable income, awareness about tissue regeneration and reinforcement treatments and increasing succes…